Market cap
$364 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
3.2
P/B Ratio
2.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 12,400.00 | 25.99 | 131.62 |
| EBIT | -- | -- | -10.27 | 0.96 | 10.77 |
| Net Profit | -10.15 | -279.81 | -169.66 | -172.17 | 4.35 |
| EPS | -9.25 | 91.38 | 68.60 | 25.82 | 14.87 |
| Book Value | -- | -- | 164.92 | -30.49 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -4,914.00 | -5,306.40 | -2,609.00 | -- | -- |
| Net Margin
| -- | -- | -6,388.20 | -- | -- |
| Return on equity
| -93.82 | -4,087.44 | -25.44 | -24.52 | -153.55 |
| Return on Capital
| -91.30 | -647.17 | -- | -24.48 | -149.28 |
| Return on Assets
| -73.81 | -133.01 | -44.61 | -23.11 | -115.82 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
-24.48
|
-149.28
|
-100.14
|
-139.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-25.44
Higher than Peers by 14.96
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-25.44
|
-24.52
|
-153.55
|
-103.40
|
-143.72
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-44.61
Lower than Peers by 13.63
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-44.61
|
-23.11
|
-115.82
|
-82.51
|
-100.87
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-2,609.00
Lower than Peers by 2,525.38
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-2,609.00
|
--
|
--
|
-4,914.00
|
-5,698.80
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-6,388.20
Lower than Peers by 6,295.53
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-6,388.20
|
--
|
--
|
-4,920.00
|
-5,704.00
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-6.39
Lower than Peers by 6.39
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-6.39
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
12,400.00
Higher than Peers by 12,346.05
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
12,400.00
|
--
|
-1.00
|
--
|
--
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-10.27
Lower than Peers by 9.47
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-10.27
|
-16.26
|
-17.43
|
13.77
|
41.17
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
-169.66
Lower than Peers by 162.36
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-169.66
|
-16.23
|
-17.38
|
13.74
|
46.42
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
68.60
Higher than Peers by 53.95
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
68.60
|
0.82
|
-0.27
|
0.83
|
0.92
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
5.46
Higher than Peers by 15.64
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
5.46
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
0.00
|
0.02
|
0.03
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
0.00
|
0.02
|
0.02
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
24.26
Higher than Peers by 18.45
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
24.26
|
28.95
|
3.24
|
5.15
|
4.89
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
24.26
Higher than Peers by 18.56
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
24.26
|
--
|
3.24
|
--
|
5.37
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-3,991.63
Lower than Peers by 3,989.54
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
-3,991.63
|
-1,677.10
|
-1,202.17
|
-819.00
|
-1,095.92
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
100.00
Higher than Peers by 80.86
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
100.00
|
--
|
--
|
59.20
|
575.20
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.01
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
0.01
|
--
|
--
|
0.02
|
0.02
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
--
|
--
|
1,158.57
|
1,160.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
1,461.00
|
1,461.00
|
-131,307.38
|
-1,736.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
120,593.38
|
116,393.00
|
112,177.41
|
3,583.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
--
|
--
|
-242,326.21
|
-4,160.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
3.17
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
3.17
|
-7.80
|
-0.98
|
-0.44
|
-0.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
2.81
Lower than Peers by 2.38
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
2.81
|
1.01
|
1.88
|
0.48
|
0.75
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.57
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
0.57
|
0.15
|
-0.31
|
0.54
|
0.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
364
Higher than Peers by 218
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Palisade Bio (PALI)
|
364
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|